| Drug Name |
Raltegravir |
| Drug ID |
BADD_D01905 |
| Description |
Raltegravir is an antiretroviral drug produced by Merck & Co., used to treat HIV infection. It received approval by the U.S. Food and Drug Administration (FDA) on 12 October 2007, the first of a new class of HIV drugs, the integrase inhibitors, to receive such approval. |
| Indications and Usage |
For the treatment of HIV-1 infection in conjunction with other antiretrovirals. |
| Marketing Status |
approved |
| ATC Code |
J05AJ01 |
| DrugBank ID |
DB06817
|
| KEGG ID |
D06676
|
| MeSH ID |
D000068898
|
| PubChem ID |
54671008
|
| TTD Drug ID |
D0I1FQ
|
| NDC Product Code |
0006-0477; 0006-3603; 50090-1085; 65977-0049; 82982-055; 17381-749; 0006-0227; 53002-1686; 71205-777; 68071-2113; 0006-3080; 0006-0473 |
| UNII |
22VKV8053U
|
| Synonyms |
Raltegravir Potassium | Potassium, Raltegravir | Raltegravir | MK 0518 | 0518, MK | MK0518 | MK-0518 | Isentress |
